Patients Views & Analysis

Views & Analysis

Patients

pharmaphorum podcast Episode 177a - Rob Abbott, ISPOR

The ins and outs of HEOR – A lever for global health

Web editor Nicole Raleigh speaks with Rob Abbott, CEO and executive director of ISPOR, about the ins and outs and trends of HEOR.

Patients

executive stand up for global health - four faces with a world map overlayed

Op-ed: Pharma must show courage, leadership on public health

Pharma companies can't claim to care about global patient wellbeing unless they stand up to Trump's public health cuts.

Patients

Black American patient with healthcare provider

Meeting patients where they are: Improving bipolar I disorde...

As a psychiatric provider working with people from all walks of life, I’ve seen how serious mental health conditions, particularly bipolar I disorder (BD-I), can present differently dependi

Patients

pharmaphorum Episode 172a - David Gillen, Norgine

Prevention for a healthier, more productive society

During Anthropy 2025: Rebooting Britain, web editor Nicole Raleigh spoke with David Gillen, chief medical officer at Norgine.

Patients

How pharma is tackling new direct-to-patient programmes

At Reuters Pharma USA, executives from AstraZeneca, Gilead, Kyowa Kirin, and EVERSANA discussed the what, why, and how of direct-to-patient models.

Patients

Reuters pharma USA 2025 Faruk Abdullah interview

Direct-to-patient is more than just telehealth – with EVERSA...

Hear from EVERSANA's Faruk Abdullah in this video interview as he explains why direct-to-patient strategies go beyond telehealth.

The ins and outs of HEOR – A lever for global health

Op-ed: Pharma must show courage, leadership on public health

Meeting patients where they are: Improving bipolar I disorde...

Prevention for a healthier, more productive society

How pharma is tackling new direct-to-patient programmes

Direct-to-patient is more than just telehealth – with EVERSA...

NHS staff 'feel unprepared for digital transformation'

How to meet your physicians where they are online

Views & Analysis

Editor's Picks